| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/16/2006 | US20060057196 Efavirenz tablet formulation having unique biopharmaceutical characteristics |
| 03/16/2006 | US20060057195 Stable solid preparations |
| 03/16/2006 | US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 03/16/2006 | US20060057193 Delivery system for pharmaceutical agents |
| 03/16/2006 | US20060057192 Localized non-invasive biological modulation system |
| 03/16/2006 | US20060057190 Silicone topcoat with improved dirt repellency and improved bondability |
| 03/16/2006 | US20060057189 Aqueous crop protection formulations comprising asulam |
| 03/16/2006 | US20060057179 Therapeutic polyesters and polyamides |
| 03/16/2006 | US20060057171 Solitonium and textile having solitonium for weight reduction |
| 03/16/2006 | US20060057168 Microemulsion process and composition |
| 03/16/2006 | US20060057167 Storable and shippable concentrates; mixable with polymer formulations without heating, homogenizing or cooling |
| 03/16/2006 | US20060057163 adjuvant compound chosen from the acrylic or methacrylic polymers and the copolymers of maleic anhydride and an alkenyl derivative especially with polyalkenyl ethers of sugars or polyalcohols; heterologus influenza protein |
| 03/16/2006 | US20060057162 Induction of cytotoxic T-lymphocyte responses |
| 03/16/2006 | US20060057150 Compositions against chicken coccidiosis |
| 03/16/2006 | US20060057147 Antibody recognizing antibody |
| 03/16/2006 | US20060057131 Malleable protein matrix and uses thereof |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057106 Freeze-dried interferon-y composition for transpulmonary administration and inhalation system therefor |
| 03/16/2006 | US20060057078 Oral care tablet |
| 03/16/2006 | US20060057075 Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof |
| 03/16/2006 | US20060057074 Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics |
| 03/16/2006 | US20060057073 Wet granulation process |
| 03/16/2006 | DE102004043863A1 Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum Tablets with place- and time-controlled drug release in the gastrointestinal tract |
| 03/16/2006 | DE102004035936A1 Mehrschichtige Arzneiform Multilayer dosage form |
| 03/16/2006 | DE102004035737A1 Emulsion useful e.g. in cosmetic (e.g. skin/face cream), pharmaceutical agent, plant protecting agent and agent for animal and human feeding, is stabilized by particle whose surface activity is temperature-dependent |
| 03/16/2006 | CA2579805A1 Methods for transmembrane treatment and prevention of otitis media |
| 03/16/2006 | CA2579786A1 Use of liposomal glucocorticoids for treating inflammatory states |
| 03/16/2006 | CA2579732A1 Tablets with site time-controlled gastrointestinal release of active ingredient |
| 03/16/2006 | CA2579711A1 Controlled release delivery system for bio-active agents |
| 03/16/2006 | CA2579695A1 Liposomal compositions of glucocorticoid and glucocorticoid derivatives |
| 03/16/2006 | CA2579533A1 Drug delivery from embolic agents |
| 03/16/2006 | CA2579492A1 Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components |
| 03/16/2006 | CA2579246A1 Phenolic antiseptic compositions and methods of use |
| 03/16/2006 | CA2579220A1 Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment |
| 03/16/2006 | CA2579043A1 Oral care composition comprising essential oils |
| 03/16/2006 | CA2579030A1 Controlled and directed local delivery of anti-inflammatory compositions |
| 03/16/2006 | CA2578540A1 Opioid dosage forms having dose proportional steady state cave and auc and less than dose proportional single dose cmax |
| 03/16/2006 | CA2578225A1 Testosterone gels comprising propylene glycol as penetration enhancer |
| 03/16/2006 | CA2519418A1 New injectable formulations containing progesterone |
| 03/15/2006 | EP1634949A1 Method for generating activated T-cells and antigen-pulsed antigen-presenting cells |
| 03/15/2006 | EP1634606A1 Drug for airway administration |
| 03/15/2006 | EP1634589A1 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 03/15/2006 | EP1634587A2 Film preparation for biphasic release of pharmacologically active or other substances |
| 03/15/2006 | EP1634586A1 Fast water-dispersible domperidone tablets |
| 03/15/2006 | EP1634585A1 Drug-containing sustained release microparticle, process for producing the same and preparation containing the microparticle |
| 03/15/2006 | EP1634583A1 Testosterone gels comprising propylene glycol as penetration enhancer |
| 03/15/2006 | EP1634499A1 Aqueous compositions for disinfection and/or sterilization |
| 03/15/2006 | EP1634498A2 Exo-S-mecamylamine formulation |
| 03/15/2006 | EP1634159A2 Ergonomic pointing device |
| 03/15/2006 | EP1633797A1 Biodegradable branched polylactide derivativescapable of forming polymeric micelles, and their preparation method and use |
| 03/15/2006 | EP1633734A2 Mucin synthesis inhibitors |
| 03/15/2006 | EP1633440A1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 03/15/2006 | EP1633431A1 Kit, device and method for controlled delivery of oxidizing agent into the skin |
| 03/15/2006 | EP1633395A1 Functionally reconstituted viral membranes containing adjuvant |
| 03/15/2006 | EP1633392A2 Vector for oral administration |
| 03/15/2006 | EP1633388A2 Liquid stabilized protein formulations in coated pharmaceutical containers |
| 03/15/2006 | EP1633369A1 Process to minimize loss through adhesion to equipment surfaces |
| 03/15/2006 | EP1633368A2 Foamable pharmaceutical compositions and methods for treating a disorder |
| 03/15/2006 | EP1633366A1 Pharmaceutical composition based on agonist of benzodiazepine |
| 03/15/2006 | EP1633334A2 A method of promoting sleep using topical administration of vasoactive agents |
| 03/15/2006 | EP1633331A1 Hard gelatin capsule containing titanium oxide with a controlled particle size and process for producing the same |
| 03/15/2006 | EP1633330A2 Extended release osmo-microsealed formulation |
| 03/15/2006 | EP1633329A1 Modified release formulations of selective serotonin re-uptake inhibitors |
| 03/15/2006 | EP1633328A1 Method and composition for stable and controlled delivery of (-)-hydroxycitric acid |
| 03/15/2006 | EP1633327A1 Method for improving stability and shelf-life of liposome complexes |
| 03/15/2006 | EP1633326A1 Transnasal microemulsions containing diazepam |
| 03/15/2006 | EP1633325A1 Oil emulsion for postnatal hormone substitution |
| 03/15/2006 | EP1633324A2 Ophthalmic compositions containing a synergistic combination of three polymers |
| 03/15/2006 | EP1633323A2 Ternary and quaternary eutectic mixtures |
| 03/15/2006 | EP1633322A2 Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof |
| 03/15/2006 | EP1633320A2 Implantable controlled release bioactive agent delivery device |
| 03/15/2006 | EP1596842A4 Dermal, transdermal, mucosal or transmucosal ingredient delivery devices |
| 03/15/2006 | EP1590004A4 Improved thickened beverages for dysphagia |
| 03/15/2006 | EP1521595B1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 03/15/2006 | EP1509206A4 A hemostatic composition |
| 03/15/2006 | EP1435908A4 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 03/15/2006 | EP1404303A4 Stable pharmaceutical compositions containing pravastatin |
| 03/15/2006 | EP1401435B1 Topical application of thiazolyl amides |
| 03/15/2006 | EP1390039B1 Use of estrogen compounds to increase libido in women |
| 03/15/2006 | EP1339414A4 L-histidine in ophthalmic solutions |
| 03/15/2006 | EP1324749B1 Medicinal aerosol formulations |
| 03/15/2006 | EP1318819A4 Treatment of trauma, and other indications |
| 03/15/2006 | EP1296679B1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 03/15/2006 | EP1250130A4 Propofol formulation with enhanced microbial inhibition |
| 03/15/2006 | EP1227802B1 Film preparation for biphasic release of pharmacologically active or other substances |
| 03/15/2006 | EP1225873B1 Amphiphilic polymeric vesicles |
| 03/15/2006 | EP1223802B1 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 03/15/2006 | EP1140044B1 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION |
| 03/15/2006 | EP1117356B1 Apparatus for improved administration of fentanyl and sufentanil |
| 03/15/2006 | EP1115375B1 Use of at least a10-hydroxy-2- decenoic acid derivative in a composition for promoting skin scaling |
| 03/15/2006 | EP1087756A4 Particulate acellular tissue matrix |
| 03/15/2006 | EP1063885B1 Xylitol compositions for treating upper respiratory conditions |
| 03/15/2006 | EP1028710A4 Topical compositions for nsai drug delivery |
| 03/15/2006 | EP0956859B1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 03/15/2006 | EP0952873B1 Use of a magnetic material for the manufacture of a medicament for use in targeted hysteresis hyperthermia |
| 03/15/2006 | CN1747822A Method of preparing biologically active formulations |
| 03/15/2006 | CN1747784A Complex coacervate encapsulate comprising lipophilic core |
| 03/15/2006 | CN1747746A Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 03/15/2006 | CN1747738A Sustained release of antifectives |
| 03/15/2006 | CN1747733A Treatment of bacterial diseases of the respiratory organs by locally applying fluoroquinolones |